Tolvaptan and Liver Damage Warnings: Tip of the Iceberg?

Jeffrey Berns talks about the FDA warnings concerning liver damage with the use of tolvaptan, recently approved for polycystic kidney disease.

Source: Medscape Nephrology Podcast - February 21, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts